PGx News

​The first CPIC Meeting was held in March at the ASCPT annual meeting!

​Despite the winter weather in Washington D.C., the meeting was well attended by scientists and clinicians from academia, industry and government. This meeting brought together individuals who are passionate about translational science and implementation. Real-world strategies for implementing pharmacogenetics were described, for example the feasibility of CYP2C19 genotyping for clopidogrel response (by IGNITE Network) Successful implementation of actionable gene-drug pairs using genotype data was included in symposium (by PharmCAT). In contrast, speakers from two centers shared their tougher challenges for implementation, in particular, use of pharmacogenetics in different ethnic groups to guide dosing of warfarin and the use of CYP2D6 genotype for tamoxifen in breast cancer. In the final session of the meeting, four spectacular scientists shared their successes and challenges of pharmacogenetics implementation in different parts of the world, from Europe, to Asia and to Africa. The huge global effort in implementation of pharmacogenetics has been aided by the support of the local health care systems for a variety of essential medicines, such as anti-coagulant, anti-HIV and anti-epileptic drugs.–PGRN-Hub Team